PEN
Penumbra, Inc.
330.36
80 x 330.12
80 x 330.93
bid
ask
+
1.40
0.43%
80 @ 04:00 PM
330.36 +0.00 (0.00%)
Ytd 6.26%
1y 19.11%
328.69
day range
330.62
225.54
52 week range
359.40
Open 328.22 Prev Close 328.96 Low 328.69 High 330.62 Mkt Cap 12.96B
Vol 635.77K Avg Vol 1.04M EPS 4.53 P/E 72.93 Forward P/E 51.77
Beta 0.84 Short Ratio 3.32 Inst. Own 95.46% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 04-22 50-d Avg 341.42 200-d Avg 287.17 1yr Est 366.86
Earning
Date For Estimate Reported Surprise surprise %
2026-04-22 2026-03 1.11 N/A N/A N/A
2026-02-25 2025-12 1.12 1.18 0.06 5.36%
2025-11-05 2025-09 0.9 0.97 0.07 7.78%
2025-07-29 2025-06 0.81 0.86 0.05 6.17%
2025-04-23 2025-03 0.66 0.83 0.17 25.76%
2025-02-18 2024-12 0.91 0.97 0.06 6.59%
Upgrade / Downgrade
Date Firm Action From To
2026-02-26 Evercore ISI Group Upgrade Outperform Outperform
2026-01-20 RBC Capital Downgrade Outperform Sector Perform
2026-01-20 Canaccord Genuity Downgrade Buy Hold
2026-01-16 Jefferies Downgrade Buy Hold
2026-01-16 Needham Downgrade Buy Hold
2026-01-16 Citigroup Downgrade Buy Neutral
Profile
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Insider Holder
Date Name Relation Quantity Description
2026-02-12 BOSE ARANI Director 259.61K Stock Award(Grant)
2025-09-02 ELSESSER ADAM Chief Executive Officer 760.04K Sale
2026-02-12 GREWAL HARPREET SINGH Director 8.82K Stock Award(Grant)
2025-02-13 KASSING DON W Director 9.91K Stock Award(Grant)
2026-02-12 LEEDS JANET Director 6.64K Stock Award(Grant)
2026-02-16 NARAYAN SHRUTHI President 30.87K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 FMR, LLC 5.13M 1.70B 13.08%
2025-12-30 Blackrock Inc. 4.14M 1.37B 10.55%
2025-12-30 Vanguard Group Inc 3.77M 1.25B 9.61%
2025-12-30 Price (T.Rowe) Associates Inc 1.64M 543.14M 4.19%
2025-12-30 State Street Corporation 1.16M 382.36M 2.95%
2025-12-30 Citadel Advisors Llc 990.28K 327.15M 2.52%
Fund Ownership
Report Date Organization Position Value Percentage
2026-01-30 iShares Trust-iShares Core S&P Mid-Cap ETF 1.25M 414.25M 3.20%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.17M 385.65M 2.97%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 844.20K 278.89M 2.15%
2025-12-30 T. Rowe Price Health Sciences Fund, Inc. 536.11K 177.11M 1.37%
2025-11-29 VANGUARD WORLD FUND-Vanguard U.S. Growth Fund 502.94K 166.15M 1.28%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 476.21K 157.32M 1.21%
Split
Split Date
1 : 10 2014-11-16